Journal article icon

Journal article

Trends in the incidence of cancers related to HIV-AIDS in Harare, Zimbabwe 1990-2019

Abstract:
Background: HIV prevalence in Harare reached a maximum of around 33% of adults in 1995, before falling to 12% in 2019. We examine trends in the incidence of Kaposi sarcoma (KS), non-Hodgkin lymphoma (NHL), Hodgkin lymphoma, and squamous cell conjunctival cancers (SCCCs) in the population of Harare in relation to changes in HIV prevalence, and the increasing availability and use of antiretroviral therapy (ART). Methods: Data from the population-based cancer registry of Harare are used to calculate incidence rates for the Black (African) population for the years 1990-2019. Results: Incidence of KS increased to a peak in the late 1990s, after which rates declined, especially at younger ages. Mean age at diagnosis increased by about 8 years in men and 6 years in women. SCCC shows a similar trend to that of KS, with a dramatic 10-fold increase in incidence, followed by an equivalent fall. Although Hodgkin lymphoma showed no change in incidence over the 30-year period, rates of NHL progressively increased. Incidence in younger adults (aged younger than 44) stabilized after about 2001 but continued to increase in older individuals. Conclusions: The availability of high-quality cancer registry data over a long period has provided a unique opportunity to study the effects of the epidemic of HIV-AIDs and of ART availability on the risk of cancer in an African population. As HIV prevalence fell and ART coverage expanded, incidence of KS and SCCC declined, whereas for NHL the trends suggest that long-term infection with HIV may pose an increased risk, despite ART.
Publication status:
Published
Peer review status:
Peer reviewed

Actions

Access Document

Files:
Publisher copy:
10.1093/jnci/djaf194

Authors

More by this author
Role:
Author
ORCID:
0000-0002-1234-0913
More by this author
Role:
Author
ORCID:
0000-0003-3538-5150
More by this author
Role:
Author
ORCID:
0000-0002-8269-7571


More from this funder
Funder identifier:
https://ror.org/05mdyn772


Publisher:
Oxford University Press
Journal:
Journal of the National Cancer Institute More from this journal
Volume:
117
Issue:
10
Pages:
2096-2102
Publication date:
2025-07-16
Acceptance date:
2025-07-08
DOI:
EISSN:
1460-2105
ISSN:
0027-8874


Language:
English
Pubs id:
2301577
Local pid:
pubs:2301577
Source identifiers:
3350872
Deposit date:
2025-10-08
ARK identifier:
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP